Wei Wei, Zhao Xiaoliang, Zhu Jianquan, Zhang Lianmin, Chen Yulong, Zhang Bin, Li Yue, Wang Meng, Zhang Zhenfa, Wang Changli
Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Lung Cancer Center, Tianjin 300060, P.R. China.
Oncol Rep. 2024 Oct;52(4). doi: 10.3892/or.2024.8785. Epub 2024 Aug 2.
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the western blotting data shown in Fig. 4B and C on p. 1952, and the Transwell invasion assay data in Fig. 2F and 4I, had already appeared in previously published articles written by different authors at different research institutes (a number of which have been retracted). Owing to the fact that the contentious data in the above article had already been published prior to its submission to , the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Oncology Reports 42: 1946‑1956, 2019; DOI: 10.3892/or.2019.7302].
在本文发表后，一位关注此事的读者提请编辑注意，第1952页图4B和C所示的某些蛋白质印迹数据，以及图2F和4I中的Transwell侵袭实验数据，已出现在不同研究机构的不同作者之前发表的文章中（其中一些文章已被撤回）。由于上述文章中存在争议的数据在提交给本期刊之前就已经发表，编辑决定将本文从该期刊撤回。已要求作者对这些问题作出解释，但编辑部未收到回复。编辑就由此造成的不便向读者表示歉意。[《肿瘤学报道》42: 1946‑1956, 2019; DOI: 10.3892/or.2019.7302]
